Simultaneous sensitive detection of multiple DNA glycosylases from lung cancer cells at the single-molecule level

Juan Hu, Minghao Liu, Ying Li, Bo Tang, Chun‐yang ZhangChemical 2017 · DOI

TL;DR

This paper presents a novel single-molecule detection method for simultaneously quantifying two key DNA repair enzymes, hOGG1 and hAAG, which are implicated in lung cancer. By designing fluorescent molecular beacons that are cleaved by these enzymes, the researchers achieve highly sensitive and selective detection, paving the way for improved diagnostics and drug screening.

What Problem Does This Paper Address?

Maintaining genomic stability is crucial, and DNA glycosylases play a vital role in repairing DNA damage through the base excision repair (BER) pathway. Mammals possess a diverse set of these enzymes, each with specific roles. However, simultaneously detecting and quantifying multiple DNA glycosylases has been a significant challenge. This is particularly relevant for diseases like lung cancer, where aberrant DNA glycosylase activity, specifically of hOGG1 and hAAG, has been identified as a potential biomarker for risk assessment and prevention. Existing methods for assaying these enzymes often suffer from limitations such as the need for radioactive labeling, low specificity, lengthy analysis times, complex procedures, and a lack of multiplexing capability. Therefore, there's a clear need for a simple, sensitive, and simultaneous detection method for these critical enzymes.

Methods

The core of this work lies in a clever single-molecule detection strategy utilizing DNA glycosylase-mediated cleavage of molecular beacons. Here's a breakdown of the key techniques:

  • Molecular Beacons: The researchers designed two distinct molecular beacons.
  • One beacon is Cy3-labeled and modified with 8-oxoguanine (8-oxoG), specifically designed to be a substrate for hOGG1.
  • The second beacon is Cy5-labeled and modified with deoxyinosine, tailored for hAAG.
  • Each beacon also incorporates a fluorescence quencher (BHQ2 for Cy3, BHQ3 for Cy5) at the opposite end, keeping the fluorescence signal low in its intact state.
  • Enzyme-Mediated Cleavage:
    • hOGG1 recognizes and removes 8-oxoG from the DNA, creating an apurinic/apyrimidinic (AP) site.
  • hAAG recognizes and removes deoxyinosine, also forming an AP site.
  • Crucially, the enzyme Apurinic/Apyrimidinic Endonuclease 1 (APE1) is used to cleave these AP sites.
  • This cleavage event breaks the molecular beacon, spatially separating the fluorophore (Cy3 or Cy5) from its quencher. This separation leads to the restoration of fluorescence.
  • Single-Molecule Detection: The restored Cy3 and Cy5 fluorescence signals are then detected and quantified using Total Internal Reflection Fluorescence (TIRF)-based single-molecule detection. This technique allows for the visualization and counting of individual fluorescent events, offering superior sensitivity and signal-to-noise ratios compared to ensemble measurements.
  • Simultaneous Detection: By using distinct fluorophores (Cy3 and Cy5) and specific substrates for each enzyme, the method allows for the simultaneous detection of both hOGG1 and hAAG in the same sample.

This approach is novel in its application of dual-labeled molecular beacons for simultaneous detection of multiple DNA glycosylases at the single-molecule level, bypassing the need for target amplification.

Datasets

Not discussed in the paper. The study focuses on developing and validating a new analytical method using synthesized substrates and biological samples (lung cancer cells).

Key Insights and Ideas

  • The Power of Molecular Beacons for Multiplexed Enzyme Detection: The ingenious design of enzyme-specific molecular beacons, coupled with a universal cleavage mechanism (APE1), provides a versatile platform for detecting multiple enzymes simultaneously.
  • Single-Molecule Sensitivity for Low-Abundance Biomarkers: The transition to single-molecule detection is critical for achieving the ultra-high sensitivity required to detect low concentrations of enzymes or even low numbers of cells, which is often the case in early disease diagnosis.
  • Direct Correlation Between Enzyme Activity and Fluorescence: The method establishes a direct, quantifiable link between the activity of hOGG1 and hAAG and the resulting Cy3 and Cy5 fluorescence signals, respectively. This is a significant improvement over indirect or ensemble-based assays.
  • Potential for Real-World Clinical Applications: The successful demonstration of detecting these enzymes in lung cancer cells highlights the method's potential for early clinical diagnosis and monitoring.

Key Results

  • Simultaneous Detection: The method successfully demonstrated the simultaneous detection of hOGG1 and hAAG using distinct Cy3 and Cy5 fluorescence signals.
  • High Sensitivity:
    • Detection limit for hOGG1: 2.23 × 10<sup>-6</sup> U μL<sup>-1</sup>.
  • Detection limit for hAAG: 8.69 × 10<sup>-7</sup> U μL<sup>-1</sup>.
  • These limits were achieved without any target amplification, representing a significant improvement over existing methods.
  • Excellent Selectivity: The assay showed high selectivity for hOGG1 and hAAG, with no significant signal observed in the presence of control enzymes like UDG and TDG, or BSA.
  • Kinetic Parameter Quantification: The single-molecule approach allowed for accurate determination of kinetic parameters (Vmax and Km) for both hOGG1 and hAAG.
  • Inhibition Assay Feasibility: The method was successfully used to evaluate the inhibitory effects of cadmium (Cd2+) on hOGG1 and hAAG, demonstrating its utility in drug screening.
  • Cellular Detection: The assay could accurately quantify hOGG1 and hAAG activity in A549 lung cancer cells, with detection limits as low as 7 cells for hOGG1 and 9 cells for hAAG.

Limitations and Future Work

  • Limitations:
    • The current method is demonstrated for two specific DNA glycosylases. While the principle is extensible, developing specific substrates for other glycosylases would be necessary.
  • The study used synthesized substrates and purified enzymes for initial validation. Further validation with more complex biological matrices might be required.
  • Future Work:
    • Extension to Other DNA Repair Enzymes: The authors explicitly suggest that this method can be extended to simultaneously detect other types of DNA repair enzymes by simply designing specific substrates for molecular beacons.
  • Broader Clinical Applications: The potential for early clinical diagnosis and drug development is highlighted, suggesting future research in these areas.
  • High-Throughput Screening: The sensitivity and multiplexing capability make this method a strong candidate for high-throughput screening of enzyme inhibitors.

Summary updated

Abstract

DNA glycosylases are involved in the base excision repair pathway, and all mammals express multiple DNA glycosylases to maintain genome stability. However, the simultaneous detection of multiple DNA glycosylase still remains a great challenge. Here, we develop a single-molecule detection method for the simultaneous detection of human 8-oxoguanine DNA glycosylase 1 (hOGG1) and human alkyladenine DNA glycosylase (hAAG) on the basis of DNA glycosylase-mediated cleavage of molecular beacons. We designed a Cy3-labeled molecular beacon modified with 8-oxoguanine (8-oxoG) for a hOGG1 assay and a Cy5-labeled molecular beacon modified with deoxyinosine for a hAAG assay. hOGG1 may catalyze the removal of 8-oxoG from 8-oxoG/C base pairs to generate an apurinic/apyrimidinic (AP) site, and hAAG may catalyze the removal of deoxyinosine from deoxyinosine/T base pairs to generate an AP site. With the assistance of apurinic/apyrimidinic endonuclease (APE1), the cleavage of AP sites results in the cleavage of molecular beacons, with Cy3 indicating the presence of hOGG1 and Cy5 indicating the presence of hAAG. Both of the Cy3 and Cy5 signals can be simply quantified by total internal reflection fluorescence-based single-molecule detection. This method can simultaneously detect multiple DNA glycosylases with a detection limit of 2.23 × 10<sup>-6</sup> U μL<sup>-1</sup> for hOGG1 and 8.69 × 10<sup>-7</sup> U μL<sup>-1</sup> for hAAG without the involvement of any target amplification. Moreover, this method can be used for the screening of enzyme inhibitors and the simultaneous detection of hOGG1 and hAAG from lung cancer cells, having great potential for further application in early clinical diagnosis.
BibTeX
@inproceedings{hu2017simultaneous,
  author = {Juan Hu and Minghao Liu and Ying Li and Bo Tang and Chun‐yang Zhang},
  title = {{Simultaneous sensitive detection of multiple DNA glycosylases from lung cancer cells at the single-molecule level}},
  booktitle = {Chemical},
  year = {2017},
  doi = {10.1039/c7sc04296e},
}
Figure